Poster Area
04 Assessment Of The Immediate Effect Of Plasmodium Falciparum Malaria Infection On Epstein Barr Virus Latency And Reactivation Using A Multiplex Serological Approach. Bonface Ariera1, Emilly Koech2, Kevin Waomba2,Rosemary Rochoford1, Sidney Ogolla2 (1USA, 2Kenya)
08 The Constitutive Heterochromatin Machinery Differentially Recognizes And Silences Self Genomes Versus Foreign EBV Genomes. Eric M. Burton, Ibukun A. Akinyemi, Tiffany R. Frey, Huanzhou Xu, Xiaofan Li, Lai Jing Su, Jizu Zhi, Michael T. McIntosh, Sumita Bhaduri-McIntosh (USA)
09 IFI16 PARTNERS WITH KAP1/TRIM28 TO MAINTAIN EBV LATENCY. Huanzhou Xu, Xiaofan Li, Tiffany R. Frey, Kevin Zhou, Lauren E. Droske,Michael T. McIntosh, Sumita Bhaduri-McIntosh (USA)
14 EBNA-LP Co-Activates OXPHOS Transcription Factors To Promote Metabolic Changes In EBV Infected B Cells. Jana Cable1, Joshua Messinger1, Robert White2, Micah Luftig1 (1USA,2UK)
17 Simplified detection of Epstein-Barr virus for diagnosis of endemic Burkitt lymphoma. Andrea Gardner, Julio Alvarez, Caitlyn Genovese, Ryan Snodgrass, Varun Kopparthy, David Erickson, Ethel Cesarman (USA)
19 Single-Cell RNA Sequencing Analysis Of Peripheral Blood Mononuclear Cells Of A Patient With Epstein-Barr Virus Associated Haemophagocytic Lymphohistiocytosis. Lo Sha Cheung1, Ka Wo Wong1, Sara SW Chan1, Janice KP Lam1, 2, Alan KS Chiang1 (1Hong Kong, 2USA)
22 Immunization With Nanoparticle Displaying Epstein-Barr Virus Gh/Gl Elicits Neutralizing Antibodies In Rhesus Macaques. Kristina Edwards, Karina Schmidt, Leah Homad, Harman Malhi, Andrew J. Borst, Jing Yang Wang, Carl Walkey, Neil P. King, Andrew McGuire(USA)
24 An In Silico-Based Virtual Screening Of Fingerroot-Derived Phytochemicals Action On Epstein-Barr Virus Lytic Replication For Ebv-Associated Malignancies Therapy. Tipaya Ekalaksananan, Ati Burassakarn, Sawarot Srisathaporn, Panwad Tongchai, Patravoot Vatanasapt, Sirinart Aronseree, Natcha Patarapadungkit, and Chamsai Pientong (Thailand)
25 Genetic Variability Of The Epstein-Barr Virus And Its Relationship With Post-Transplant Lymphoproliferative Disorders. Torrá FL; Durand KA; Perez C; Bernáldez P; Solernou V; Bosaleh A; Balbarrey Z; Picconi MA; Fellner MD(Argentina)
26 Toward The Harmonization Of The Epstein-Barr Virus (EBV) Realtime PCR Quantification Methods Used In Argentina. María Dolores Fellner, Karina Durand, Marcelo Rodriguez, Lucía Irazu, María Alejandra Picconi (Argentina)
28 Detecting and treating children with lymphoma in Africa earlier to improve treatment outcomes. Ferraresso Marta (UK)
30 Syncytin-1 Promotes Epstein-Barr Virus Lytic Replication Through Pi3k/Akt Signaling. Tiffany R. Frey, Ibukun A. Akinyemi, Sumita Bhaduri-McIntosh, and Michael T. McIntosh (USA)
34 Ebvirumab: A Novel Human Antibody To Treat Acute Epstein-Barr Virus Infection And Prevent Its Associated Diseases. Kristine Hua, Shane Horsefield, Kirrilee Beckett, Corey Smith, Martina Jones, Bostjan Kobe and Rajiv Khanna (Australia)
41 The direct and Structural Unique Interaction of LMP1 and TRAF6 mediates LMP1 signaling and virus-driven B cell lymphoma. Fabian Giehler1, Michael S. Ostertag1, Thomas Sommermann1, Daniel Weidl1, Kai R. Sterz1, Helmut Kutz1, Brigitte Biesinger1, Grzegorz M. Popowicz1, Johannes Kirchmair2, Arnd Kieser1 (1Germany, 2Austria)
44 Genomic Structure Of Epstein-Barr Virus As Identified By Hidden Markov Model Clustering. Anastasia Lankina, Cristina Venturini, Oscar Charles, Richard Goldstein, Judith Breuer (UK)
46 The Epstein-Barr Virus Deubiquitinating Enzyme BPLF1 Regulates ER Homeostasis By Preventing Ufmylation. Jiangnan Liu, Francisco Aguilar Alonso, Francisco Esteves, Noemi Nagy, Maria G. Masucci (Sweden)
53 Do EBNA2 Allelic Variants Contribute To The EBV Role In Multiple Sclerosis? Mechelli R,Ilari S, Buscarinu MC, Romano S, Chiara M, Bellucci G, Bigi R, De Robertis M, D’Erchia AM, Picardi E, Manzari C, Mansi L, Marnetto F, Valentino P, Bertolotto A, Capobianco M, Lorefice L, Cocco E, Castelli M, Marfia GA, Centonze D, Horner D, Pesole G, Ristori G, Salvetti M (Italy)
54 DIFFERENTIATION-INDUCED SYNTHESIS OF BLIMP1 LEADS TO XBP-1s SYNERGIZING WITH B-ZIP PROTEINS TO PROMOTE LYTIC EBV
REACTIVATION IN EPITHELIAL CELLS. Richard J. Kraus, Sarah Yuan, Jessica A. Reusch, Katherine Lambert, Parita Patel, Kathleen R. Makielski, Paul F. Lambert, and Janet E. Mertz (USA)
57 Genetic and environmental risk factors associated with EBV seroconversion. Marisa D. Muckian1, Dr. James F. Wilson1, Dr. Graham S. Taylor1, Dr. Helen R. Stagg1, Dr. Nicola Pirastu1,2 (1UK, 2Italy)
58 Induction of impdh2 and Nucleolar Hypertrophy Are Required for Growth Transformation of Resting B Cells by EBV. Takayuki Murata, Atsuko Sugimoto, Takahiro Watanabe, Yusuke Yanagi, Kazuhiro Matsuoka, Yusuke Okuno, Yoshitaka Sato, Teru Kanda, Yasumasa Iwatani, Hiroshi Kimura(Japan)
63 Analysis of chromatin structural aberrations in Epstein-Barr virus (+) Burkitt lymphoma. Atsushi Okabe 1, Takahiro Fujii 1, Masaki Fukuyo 1, Bahityar Rahmutulla 1, Hironori Yoshiyama 1, Patrick Tan 2, Atsushi Kaneda (1Japan, 2Singapore)
65 Induction Of Histone Modification As Target Of Andrographolide On Inhibition Of Epstein-Barr Virus Lytic Production In Ebv Positive Cancer Cell Lines. Praphatson Malat, Tipaya Ekalaksananan, Chukkris Heawchaiyaphum, Supawadee Suebsasanaand and Chamsai Pientong (Thailand)
68 Characterization of cellular fates in Epstein Barr Virus-infected cells. Nicolás M. Reinoso-Vizcaino, Elliott D. SoRelle, Micah A. Luftig (USA)
69 CHARACTERIZATION OF CIRC-VIRF4 IN KAPOSI’S SARCOMA-ASSOCIATED HERPESVIRUS. Soleil Torres, Vaibhav Jain, Lauren Gay, Daniel Stribling, Melody Baddoo, Stuart Le Grice, Jason Rausch, Jiaqiang Zhu, Michael Harris, Erik Flemington, Scott Tibbetts, & Rolf Renne (USA)
74 ISOFORM-SPECIFIC FUNCTIONS OF THE HOST TRANSCRIPTION FACTOR, LYMPHOID ENHANCER FACTOR 1 (LEF1) IN EBV LATENCY AND REACTIVATION
BJ Ward and Rona S. Scott
75 EBV presence in the brain of persons with multiple sclerosis: new evidence using rnascope technology. Barbara Serafini, Barbara Rosicarelli, Francesca Aloisi (Italy)
76 Leveraging diverse epithelial cell line models to study EBV latency and identify cellular restriction factors of infection. Lyla J. Stanland and Micah A. Luftig (USA)
79 Size And Transcriptional Activation Differences Of B95-8 ZTA Versus Akata And P3HR-1 ZTA Map To Specific Amino Acids In The Transactivation Domain. Trenton Mel Church, Dinesh Verma, Sankar Swaminathan (USA)
81 Construction Of A KSHV Infected Telomerase Immortalized Endothelial Cell Line Permissive Of Robust Lytic Virus Replication And Virus Production. Zola Wagner1, Dinesh Verma1, Trenton Church1, Rolf Renne2 and Sankar Swaminathan (USA)
83 The Landscape Of EBV Expression In Cancer And Stromal Cells. Yarong Tian, Guojiang Xie, Isak Holmqvist, Alan Bäckerholm, Sanna Abrahamsson, Jonas Carlsten, Ka-Wei Tang (Sweden)
84 EBV-defective genomes in different cell-types are associated with EBV-related malignancies. Cristina Venturini1, Ben Carpenter2, Claire Booth3, Winnie Ip3, Austen Worth3, Judith Breuer (UK)
87 Functional characterization of EBER2 variants of Epstein-Barr virus in the pathogenesis of nasopharyngeal carcinoma. Wenjin Wan, Sung Chul Kwon, Alan KS Chiang (China)
90 Genomic Diversity Of Epstein-Barr Virus Harbored In PBMC, Plasma And Saliva Of Children With EBV-Associated Lymphoproliferative Diseases. Ka Wo Wong1, Janice KP Lam1, Kwok Hung Chan2, Wanling Yang1, Alan KS Chiang (China)
92 EBV BORF2 Promotes G1/S Cell Cycle Arrest Through Interactions With P53 And APOBEC3B. Jaime Yockteng-Melgar1,2, Adam Z. Cheng3, Natasha Malik-Soni1, Reuben S. Harris3 and Lori Frappier1 (1Canada, 2Ecuador, 3USA)
94 Repurposing of tumor virus exosomes into anti-cancer agents. Dirk P. Dittmer, Ryan McNamara, Rachele Bigi, Yijun Zhou (USA)
93 EBNA3C reprograms host 3D genome organization to control the growth of lymphoblastoid cell line (LCL). Chong Wang1, Weiyue Ding1, Hongbo Wang1, Yohei Narita1, Merrin Leong1, Mingxiang Teng2, Bo Zhao1 (1USA)
104 EPSTEIN-BARR VIRUS HIJACKS BRD7 TO CONTROL C-MYC-MEDIATED VIRAL LATENCY MAINTENANCE. Shen Li, Li Yang, Yanling Li, Wenxing Yue, Shuyu Xin, Jianhong Lu (China)
108 ASSESSMENT OF THE IMPACT OF MYCOTOXINS ON THE EPIGENOME AND THEIR SYNERGISTIC ROLE WITH EPSTEIN BARR VIRUS (EBV) IN ENDEMIC BURKITT LYMPHOMA (EBL) IN AFRICAN CHILDREN.
Grace Akinyi Odongo 1 , Francesca Manara, Antonin Jay 1 ,Mohamed Ali Maroui 1 , Fabrice Mure 1 , Thanos Mouchtaris-Michailidis 2 , Tarik Gheit 1 ,
Audrey Diederichs, Cecilia Sirand 1 , Cyrille Cuenin 1 , Lucia Mundo 4 , HectorHernandez-Vargas 1 , Lorenzo Leoncini 4 , Laeticia Toe 2 , Patrick Kolsteren 2 , Carl Lachat 2 , Marthe De Boevre 2 , Sarah De Saeger 2 , Rosita Accardi, Henri Gruffat 1 , Rita Khoueiry 1 , Zdenko Herceg 1 (France 1, Belgium 2 , Burkina Faso 3 , Italy 4 )
109 SIRT2 Inhibition Suppresses Lytic And Latent EBV Infection. Ashley P Barry, Stacy Remiszewski, Lillian Chiang, Thomas Shenk, Micah A Luftig (USA)
110 EBV colonic cell infection promotes inflammation and predisposes to colon carcinogenesis. Santarelli R., Gonnella R., Evangelista L., Pompili C., Rossi A.,Gilardini Montani M.S., Cirone M (Italy)
111 MODULATION OF MIR-663A EXPRESSION BY EBV-ENCODED G PROTEIN–COUPLED RECEPTOR (GPCR), BILF1, IN BURKITT LYMPHOMA
Ciara Leahy 1 , Katerina Vrzalikova 4 , Eanna Fennel 1 , Matthew Pugh 3 , Maria Chiara Siciliano 2 , Lynnette Marcar 1 , Andrew Bell 4 , Paul Murray 1 , Stefano Lazzi 2 , Lorenzo Leoncini 2 , Lucia Mundo 1,2